Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cédric Pastoret

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Hematology. American Society of Hematology. Education Program|December 7, 2024
Large granular lymphocyte leukemia: a clonal disorder with autoimmune manifestationsTony Marchand, Cédric Pastoret, Aline Moignet, et al.
Frontiers in Oncology|February 18, 2022
Toward a Better Classification System for NK-LGL DisordersGaëlle Drillet, Cédric Pastoret, Aline Moignet, et al.
International Journal of Laboratory Hematology|December 16, 2020
A reduced panel of eight genes (ATM, SF3B1, NOTCH1, BIRC3, XPO1, MYD88, TNFAIP3, and TP53) as an estimator of the tumor mutational burden in chronic lymphocytic leukemiaJasmine Chauzeix, Cédric Pastoret, Lucie Donaty, et al.
Nature Communications|November 14, 2017
IL-2 imprints human naive B cell fate towards plasma cell through ERK/ELK1-mediated BACH2 repressionNicolas Hipp, Hannah Symington, Cédric Pastoret, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 16, 2023
Five new F10 variants in hereditary factor x deficiency detected by high-throughput sequencingCédric Pastoret, Clémentine Wahl, Sabine Castet, et al.
Ejhaem|September 29, 2025
<i>NOTCH1</i> Mutation Is Associated With Response to Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: A Retrospective StudyClémence Haméon, Roch Houot, Emmanuel Gyan, et al.
The American Journal of Dermatopathology|December 11, 2024
Differential Expression of p53 in Mycosis Fungoides, Sezary Syndromes, and Their Transformed FormsAnna Courtois, Pierre Allaume, Maxime Raby, et al.
Clinical and Experimental Dermatology|February 17, 2024
Clinical and histological features of histiocytoid Sweet syndrome associated with VEXAS syndromeHortense Lecoeuvre, François Le Gall, Cécile Le Naoures, et al.
Therapeutic Drug Monitoring|September 17, 2020
Redefining Therapeutic Drug Monitoring of Tacrolimus in Patients Undergoing Liver Transplantation: A Target Trough Concentration of 4-7 ng/mL During the First Month After Liver Transplantation is Safe and Improves Graft and Renal FunctionFlorian Lemaitre, Camille Tron, Thomas Renard, et al.
British Journal of Haematology|April 19, 2024
Efficacy of ruxolitinib in the treatment of relapsed/refractory large granular lymphocytic leukaemiaTony Marchand, Cédric Pastoret, Gandhi Damaj, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Hematology. American Society of Hematology. Education Program|December 7, 2024
Large granular lymphocyte leukemia: a clonal disorder with autoimmune manifestationsTony Marchand, Cédric Pastoret, Aline Moignet, et al.
Frontiers in Oncology|February 18, 2022
Toward a Better Classification System for NK-LGL DisordersGaëlle Drillet, Cédric Pastoret, Aline Moignet, et al.
International Journal of Laboratory Hematology|December 16, 2020
A reduced panel of eight genes (ATM, SF3B1, NOTCH1, BIRC3, XPO1, MYD88, TNFAIP3, and TP53) as an estimator of the tumor mutational burden in chronic lymphocytic leukemiaJasmine Chauzeix, Cédric Pastoret, Lucie Donaty, et al.
Nature Communications|November 14, 2017
IL-2 imprints human naive B cell fate towards plasma cell through ERK/ELK1-mediated BACH2 repressionNicolas Hipp, Hannah Symington, Cédric Pastoret, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 16, 2023
Five new F10 variants in hereditary factor x deficiency detected by high-throughput sequencingCédric Pastoret, Clémentine Wahl, Sabine Castet, et al.
Ejhaem|September 29, 2025
<i>NOTCH1</i> Mutation Is Associated With Response to Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: A Retrospective StudyClémence Haméon, Roch Houot, Emmanuel Gyan, et al.
The American Journal of Dermatopathology|December 11, 2024
Differential Expression of p53 in Mycosis Fungoides, Sezary Syndromes, and Their Transformed FormsAnna Courtois, Pierre Allaume, Maxime Raby, et al.
Clinical and Experimental Dermatology|February 17, 2024
Clinical and histological features of histiocytoid Sweet syndrome associated with VEXAS syndromeHortense Lecoeuvre, François Le Gall, Cécile Le Naoures, et al.
Therapeutic Drug Monitoring|September 17, 2020
Redefining Therapeutic Drug Monitoring of Tacrolimus in Patients Undergoing Liver Transplantation: A Target Trough Concentration of 4-7 ng/mL During the First Month After Liver Transplantation is Safe and Improves Graft and Renal FunctionFlorian Lemaitre, Camille Tron, Thomas Renard, et al.
British Journal of Haematology|April 19, 2024
Efficacy of ruxolitinib in the treatment of relapsed/refractory large granular lymphocytic leukaemiaTony Marchand, Cédric Pastoret, Gandhi Damaj, et al.
Pageof 3